Announcements Trials
Browse Landscape

Phase

Phase 2 17Phase 1/2 13Phase 1 9Phase 3 8Phase NA 2Phase EARLY_PHASE1 2

Status

Recruiting 2Unknown 1Terminated 1Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER_GOV 1OTHER 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 1Breast 1

Conditions

Carcinoma, Hepatocellular 1Advanced HR - Positive, HER2 - Negative Breast Cancer 1

Interventions

Blood Specimen Collection 106Standard of Care 82Exercise 68Radiotherapy 54Radiosurgery 47Magnetic Resonance Spectroscopy 46Specimen Handling 45Practice Guidelines as Topic 44Surveys and Questionnaires 43Interviews as Topic 43Educational Status 42Methods 41Drug Therapy 34Early Intervention, Educational 30Surgical Procedures, Operative 29Palliative Care 25Biopsy 24Control Groups 21venetoclax 17Therapeutics 17Patient Navigation 17Cisplatin 17Proton Therapy 15Magnetic Resonance Imaging 15Behavior Therapy 15Neoadjuvant Therapy 14Cognitive Behavioral Therapy 13Acupuncture Therapy 13Resistance Training 12Nutritional Status 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Recruiting × palbociclib × Clear all
NCT06856200 2025-03-04

A Study of Sirolimus (Albumin-Bound) in Combination With Palbociclib and Fulvestrant for the Treatment of Advanced Breast Cancer

Fudan University

Phase NA Recruiting
36 enrolled
Breast

Advanced HR - Positive, HER2 - Negative Breast Cancer

NCT06478927 2024-06-27

Backline Treatment of Advanced Hepatocellular Carcinoma With Palbociclib

Henan Cancer Hospital

Phase NA Recruiting
22 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡